‘Mind blowing’: Wearable devices detect CRS hours earlier among CAR-T recipients

Wearable devices accelerated detection of a common and potentially life-threatening complication among patients with multiple myeloma who underwent chimeric antigen receptor T-cell therapy, according to results of a pilot study.The technology identified signs of cytokine release syndrome several hours earlier than standard hospital monitoring.